Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Morphine sulfate
Orphan Australia Pty Ltd
Medicine Registered
_Consumer Medicine Information_ _DepoDur_ _®_ DEPODUR ® MORPHINE SULFATE 10 MG/ML MODIFIED RELEASE SUSPENSION FOR INJECTION CONSUMER MEDICINE INFORMATION WHAT IS THIS LEAFLET? This leaflet answers some common questions about DepoDur modified release suspension for injection. It does not contain all of the available information. It does not take the place of talking to your doctor. All medicines have risks and benefits. Your doctor has weighed the risks of you being given DepoDur against the benefits they expect it will have for you. If you have any concerns about being given DepoDur, ask your doctor or the medical staff looking after you. Keep this leaflet. You may need to read it again. WHAT DEPODUR IS USED FOR DepoDur modified release suspension for injection is used to provide pain relief immediately following a surgical operation (orthopaedic, abdominal, or pelvic). The morphine sulfate in DepoDur will be released over time to provide pain relief for up to 48 hours, decreasing the need for other pain medication. DepoDur contains the active ingredient, morphine sulfate. Morphine sulfate belongs to a group of medicines called opioids. These agents are used to relieve pain. The inactive ingredients include cholesterol, triolein, tricaprylin, dioleoylphosphatidylcholine, dipalmitoylphosphatidylglycerol, sodium chloride, diluted (10%) hydrochloric acid, and water for injections. Your doctor may have prescribed DepoDur for another use. Ask your doctor if you have any questions about why DepoDur has been prescribed for you. The morphine in DepoDur can be addictive. Patients with a history of opioid or other substance abuse would be considered to be at greater risk of addiction or abuse. You should discuss this with your doctor. BEFORE YOU ARE GIVEN DEPODUR DepoDur modified release suspension for injection is not suitable for everyone. Read the complete document
_Product Information _ _ _ _DepoDur_ ® _ _ PRODUCT INFORMATION DEPODUR ® 10 MG/ML MODIFIED RELEASE SUSPENSION FOR INJECTION (FOR EPIDURAL USE ONLY) NAME OF DRUG Morphine sulfate Molecular Formula: C 34 H 40 N 2 O 10 S z 5H 2 O Molecular Weight: 758.83 CAS Registry Number: 6211-15-0 DESCRIPTION DepoDur is an extended-release formulation of morphine sulfate for epidural injection. Morphine sulfate is also known as 7, 8-didehydro-4, 5α-epoxy-17-methylmorphinan-3, 6 α -diol sulfate (2:1) (salt) pentahydrate. DepoDur is a sterile, non-pyrogenic, white to off-white homogeneous suspension presented in a ready-to-use single dose vial, containing 10 mg of morphine sulfate encapsulated in multivesicular lipid-based particles (DepoFoam™ matrix) as 1 mL in normal saline. The median diameter of the lipid-based particles is in the range of 17 to 23 μm. DepoDur also contains cholesterol, triolein, tricaprylin, dioleoylphosphatidylcholine, dipalmitoylphosphatidylglycerol, sodium chloride, diluted (10%) hydrochloric acid and water for injections. Morphine base has a pKa of 7.9, with an octanol/water partition coefficient of 1.42 at physiologic pH 7.4. At this pH, morphine’s tertiary amino group is mostly ionized, making the molecule water-soluble. The pH of DepoDur is in the range of 5.0 to 8.0. DepoDur contains no antimicrobial agent. DepoDur is for single use in one patient only. Discard any residue. PHARMACOLOGY PHARMACODYNAMIC PROPERTIES Pharmacotherapeutic group: Natural opium alkaloid ATC Code: N02A 01 _ _ _Page 1 of 15 _ _Product Information _ _ _ _DepoDur_ ® _ _ Epidural administration of morphine sulfate results in analgesia without attendant loss of motor, sensory, or sympathetic function. As compared to systemic administration of morphine at comparable doses, epidurally administered morphine results in improved analgesia with increased duration. D Read the complete document